Simpson Thacher is representing WW International, Inc. (Nasdaq: WW) (“WeightWatchers”) in connection with its entry into a definitive agreement to acquire Weekend Health, Inc., d/b/a Sequence (“Sequence”). Pursuant to the terms of the definitive agreement, WeightWatchers will acquire Sequence in a cash and equity transaction valued at $132 million.
WeightWatchers is a human-centric technology company powered by its proven, science-based, clinically effective weight loss and weight management program. For nearly six decades, WeightWatchers has inspired millions of people to adopt healthy habits for real life. WeightWatchers combines technology and community to help members reach and sustain their goals on its program.
Sequence is a subscription telehealth platform offering access to healthcare providers specializing in chronic weight management. Sequence seamlessly integrates the patient and clinician experience for ongoing, clinical care and medication management while providing high-touch support in navigating the insurance process.
The Simpson Thacher team included Naveed Anwar, Anthony Vernace, Megan Whitman, Matthew Walls and Christian Sheets (M&A); Kenneth Wallach and Evan Zuckerman (Capital Markets); Vanessa Burrows and Tera Rule (Healthcare); David Rubinsky, Jeffrey Penn, Ryan Kenny and Sara Mazurek (Executive Compensation and Employee Benefits); Sophie Staples and Ruoxi Zhang (Tax); Jessica Cohen, Bobbie Burrows and Suyoung Jang (Intellectual Property); Charlie Mathes and Siobhan Lam (PCAP); and Brian Steinhardt (Credit).